Dr. Fan is the co-founder and Chief Scientific Officer of Legend Biotech, a subsidiary of GenScript and a global biopharmaceutical company focused on discovery and development of novel cell therapies.
Dr. Fan earned his Doctor of Medicine degree at Xi’an Jiaotong University, China, and completed his surgical residency at the Jiaotong University Kidney Transplant Center, China. Dr. Fan later obtained his Doctor of Philosophy in applied immunology at Hiroshima University, Japan, and completed postdoctoral training in the field of human B-cell tolerance at the Hospital for Sick Children at the University of Toronto, Canada. Dr. Fan has been published in numerous peer-reviewed academic journals and awarded a “New Key Opinion Leader” by the International Society of Transplantation.